首頁 > 市場調查報告書 > 醫療設備

透析設備

市場調查報告書

商品編碼

1560810

全球攜帶式血液透析市場 - 2024 - 2031

Global Portable Hemodialysis Market - 2024 - 2031

出版日期: 2024年09月23日 | 出版商:

DataM Intelligence | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

報告概述

2023年，全球攜帶式血液透析市場規模達到202億美元，預計2031年將達到353.8億美元，2024-2031年預測期間複合年成長率為7.4%。

血液透析是一種替代腎臟工作以清除血液中廢物和多餘液體的治療。這是透過一種稱為透析器或人工腎臟的特殊過濾器來完成的。血液通過塑膠管進入透析器，在那裡進行清潔，然後返回患者體內。每次治療開始時，將兩根針插入通路中。這些針連接到將血液輸送到透析器的塑膠管。任何時間只有少量血液從體內流出。透析機將血液泵入透析系統並控制治療時間、溫度、液體移除和壓力。

攜帶式血液透析裝置是一種醫療裝置，其可以輕鬆地從一個位置移動到另一個位置，從而對患者有利並且可以將該裝置攜帶到患者所在地。如今，腎臟疾病和病症正在以驚人的速度增加，這增加了對攜帶式血液透析產品的需求。

市場動態：

司機

慢性腎臟疾病盛行率增加

全球攜帶式血液透析市場的需求由多種因素驅動。慢性腎臟疾病盛行率的上升推動了市場的成長。

此外，技術進步的增加將推動對治療的需求。例如，根據 nih.gov 報導，慢性腎臟病是一種進行性疾病，影響全球 10% 以上的總人口，總計超過 8 億人。慢性腎病在老年人、女性、少數族裔以及患有糖尿病和高血壓的人中更為常見。慢性腎臟病對低收入和中等收入國家來說是一個特別沉重的負擔，而這些國家最沒有能力應對其後果。

例如，根據美國國家腎臟基金會的數據，目前全球有超過 200 萬人接受透析或腎臟移植治療以維持生命，但這一數字可能只佔真正需要治療才能生存的人的 10%。據估計，在中國和印度等發展中國家，老年人口數量不斷增加，腎衰竭病例數將不成比例地增加。在接受腎衰竭治療的 200 萬人中，大多數人僅在美國、日本、德國、巴西和義大利這五個國家接受治療。這五個國家僅佔世界人口的12%。在佔世界人口 50% 以上的約 100 個發展中國家，只有 20% 的人得到治療。

限制

與手術相關的併發症和人們缺乏意識等因素預計將阻礙市場。根據美國國家腎臟基金會統計，全球10%的人口受到慢性腎臟病的影響，慢性腎臟病是第12大常見死因。每年有數百萬人因無法獲得負擔得起的治療而死亡。

細分市場分析

全球攜帶式血液透析市場根據產品、泵浦系統、最終用戶和地區進行細分。

該細分市場攜帶式設備約佔全球攜帶式血液透析市場佔有率的49.7%

預計攜帶式設備領域將在預測期內佔據最大的市場佔有率。在這一領域，技術進步以及私人製造商用於設備開發的資金不斷增加將推動該市場的發展。

例如，2024年3月，總部位於荷蘭Bussum的醫療科技公司Nextkidney宣布開發出全球第一台攜帶式血液透析設備Neokidney。據這家荷蘭公司稱，Neokidney 正處於最後開發階段，預計將於 2024 年在荷蘭推出。

此外，2024年8月，醫療器材製造商Synopex取得食品藥物安全部（MFDS）的上市許可，為國內首個自主研發的重症監護病患連續性腎臟替代治療（CRRT）設備。

市場地理分析

北美約佔全球攜帶式血液透析市場佔有率的42.3%

預計北美地區將在預測期內佔據最大的市場佔有率。該地區慢性腎臟病發病率的上升、技術的進步以及資金分配的增加有助於推動市場發展。

例如，根據美國腎臟基金會的統計，估計有 3550 萬美國人患有腎臟疾病。大約 808,000 名美國人患有腎衰竭。超過 557,000 名美國人正在接受透析。腎臟疾病正以驚人的速度成長。目前，超過七分之一（或 14%）的美國成年人受到該疾病的影響，有色人種患腎衰竭的風險更大。 There were about 135,000 Americans newly diagnosed with kidney failure in 2021. 9 out of 10 people with kidney disease are unaware they have it, and 1 in 3 of those with severely reduced kidney function (but not yet on dialysis) are unaware they have kidney疾病.

此外，2023 年 9 月，AWAK Technologies 獲得了超過 2,000 萬美元的 B 輪融資，用於其在美國進行的穿戴式透析設備的關鍵試驗。 AWAK PD 是一款超攜帶式腹膜透析 (PD) 系統，可讓腎臟病患者在家中或在旅途中的任何地方接受透析。該公司將把所得款項用於各種重要舉措，以完成與新加坡中央醫院正在進行的人體關鍵前臨床研究。這筆資金還將幫助該公司改進超攜帶式 PD 設備，以進行預計 2025 年在美國開始的最終關鍵試驗。

Hemodialysis is a treatment that replaces the work of one's kidneys to clear wastes and extra fluid from the blood. This is done using a special filter called a dialyzer or artificial kidney. The blood travels through plastic tubing to the dialyzer, where it is cleaned and then returned to the patient. At the beginning of each treatment, two needles are placed into the access. These needles are connected to the plastic tubing that carries the blood to the dialyzer. Only a small amount of blood is out from the body at any one time. The dialysis machine pumps the blood through the dialysis system and controls the treatment time, temperature, fluid removal, and pressure.

A portable hemodialysis device is a medical device, which can be moved from one location to another location easily so that it is beneficial for the patient and the device can be carried to the patient's location. Nowadays, kidney diseases and disorders are increasing at an alarming rate which is increasing the need for portable hemodialysis products.

Market Dynamics: Drivers

Increasing prevalence of chronic kidney disorders

The demand for the global portable hemodialysis market is driven by multiple factors. The rising prevalence of chronic kidney disorders propels the market growth.

Furthermore, the demand for treatment will be fueled by the increase in technological advancements. For instance, according to nih.gov, chronic kidney disease is a progressive condition that affects >10% of the general population worldwide, amounting to >800 million individuals. Chronic kidney disease is more prevalent in older individuals, women, racial minorities, and people experiencing diabetes mellitus and hypertension. Chronic kidney disease represents an especially large burden in low- and middle-income countries, which are least equipped to deal with its consequences.

For instance, according to the National Kidney Foundation, over 2 million people worldwide currently receive treatment with dialysis or a kidney transplant to stay alive, yet this number may only represent 10% of people who actually need treatment to live. It is estimated that the number of cases of kidney failure will increase disproportionately in developing countries, such as China and India, where the number of elderly people is increasing. Of the 2 million people who receive treatment for kidney failure, the majority are treated in only five countries - the United States, Japan, Germany, Brazil, and Italy. These five countries represent only 12% of the world's population. Only 20% are treated in about 100 developing countries that make up over 50% of the world population.

Restraints

Factors such as complications linked with the procedure and lack of awareness among people are expected to hamper the market. According to statistics from the National Kidney Foundation in the United States, 10 percent of the world's population is affected by chronic kidney disease and it is the 12th most common cause of death. Millions die annually due to a lack of access to affordable treatment.

Market Segment Analysis

The global portable hemodialysis market is segmented based on product, pumping system, end-user, and region.

The segment portable devices accounted for approximately 49.7% of the global portable hemodialysis market share

The portable devices segment is expected to hold the largest market share over the forecast period. In this segment, the technological advancements, and rising funds for private manufacturers for device development would drive this market.

For instance, in March 2024, Bussum, the Netherlands-based Nextkidney, a medtech company, announced that it has developed the world's first portable hemodialysis device, Neokidney. According to the Dutch company, Neokidney is in the final development phase and is expected to launch in the Netherlands by 2024.

Moreover, in August 2024, Synopex, a medical device manufacturer, obtained marketing authorization from the Ministry of Food and Drug Safety (MFDS) for the nation's first independently developed continuous renal replacement therapy (CRRT) device for critical care patients.

Market Geographical Analysis

North America accounted for approximately 42.3% of the global portable hemodialysis market share

North America region is expected to hold the largest market share over the forecast period. The rising incidence of chronic kidney diseases, technological advancements, and increase in fund allotment in this region, help to propel the market.

For instance, according to American Kidney Fund, An estimated 35.5 million Americans have kidney disease. About 808,000 Americans are living with kidney failure. More than 557,000 Americans are on dialysis. Kidney disease is growing at an alarming rate. It currently affects more than 1 in 7 (or 14%) of American adults, with people of color at greater risk for kidney failure. There were about 135,000 Americans newly diagnosed with kidney failure in 2021. 9 out of 10 people with kidney disease are unaware they have it, and 1 in 3 of those with severely reduced kidney function (but not yet on dialysis) are unaware they have kidney disease.

Moreover, in September 2023, AWAK Technologies obtained more than $20m in Series B funding for the US-based pivotal trial of its wearable dialysis device. AWAK PD, the ultra-portable peritoneal dialysis (PD) system allows kidney disease patients to undergo dialysis at home and anywhere on the go. The company will use the proceeds for various crucial initiatives to conclude its ongoing human pre-pivotal clinical study with Singapore General Hospital. The funding will also help the company improve the ultraportable PD device for the final pivotal trial in the US, anticipated to begin in 2025.

Market Segmentation

By Product

Portable Devices

Consumables

Blood Lines

Dialyzer and Dialysate

Software and Services

Others

By Pumping System

Single Pump

Double Pump

By End-User

Hospitals

Specialty Clinics

Dialysis Centers

Homecare

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the global portable hemodialysis market include NxStage Medical Inc., Quanta Dialysis Technologies, Cantel Medical Group of Companies, AWAK Technologies, Medtronic, SB Kawasumi Laboratories, Texas Instruments Incorporated., Baxter, Diality, and Teleflex Incorporated. among others.

Key Developments

In April 2023, AWAK Technologies, a Singapore-based medical technology company, recently received FDA Breakthrough Device designation for their wearable and portable dialysis device. The AWAK Peritoneal Dialysis device, or AWAK PD, uses AWAK's patented sorbent technology and offers a convenient means of dialysis for renal disease patients.

In June 2022, NextKidney recently announced that it had acquired Dialyss Pte. Ltd. to boost the development of its portable Neokidney hemodialysis device. NextKidney officials boast that the Neokidney will be a small, user-friendly, home hemodialysis device, using only 4 liters of fluid per session. In addition, they say that it can run entirely independent of water supply and drain, enabling people to use it anytime and anywhere.

Why Purchase the Report?

To visualize the global portable hemodialysis market segmentation based on product, pumping system, end-user, and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development

Excel data sheet with numerous data points of global portable hemodialysis market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in Excel consisting of key products of all the major players.

The global portable hemodialysis market report would provide approximately 51 tables, 54 figures, and 181 Pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Pumping System
3.2. Snippet by Product
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Prevalence of Chronic Diseases
  - 4.1.1.2. Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Complications Linked With Procedure
  - 4.1.2.2. Lack of Awareness
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Portable Devices*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Consumables
6.4. Software and Services
6.5. Others

7. By Pumping System

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pumping System
- 7.1.2. Market Attractiveness Index, By Pumping System
7.2. Single Pump*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Double Pump

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Dialysis Centers
8.5. Homecare
8.6. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pumping System
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. The U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pumping System
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pumping System
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pumping System
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pumping System
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. NxStage Medical Inc. *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Quanta Dialysis Technologies
11.3. Cantel Medical Group of Companies
11.4. AWAK Technologies
11.5. Medtronic
11.6. SB Kawasumi Laboratories
11.7. Texas Instruments Incorporated. Incorporated.
11.8. Baxter
11.9. Diality
11.10. Teleflex Incorporated. (*LIST NOT EXHAUSTIVE)